0001493152-21-023888.txt : 20210927 0001493152-21-023888.hdr.sgml : 20210927 20210927171535 ACCESSION NUMBER: 0001493152-21-023888 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210827 FILED AS OF DATE: 20210927 DATE AS OF CHANGE: 20210927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Diamantis Christopher Eric CENTRAL INDEX KEY: 0001578723 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35141 FILM NUMBER: 211282695 MAIL ADDRESS: STREET 1: 400 SOUTH AUSTRALIAN AVENUE STREET 2: 8TH FLOOR CITY: WEST PALM BEACH STATE: FL ZIP: 33401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rennova Health, Inc. CENTRAL INDEX KEY: 0000931059 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 680370244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 BUSINESS PHONE: 561-855-1626 MAIL ADDRESS: STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 FORMER COMPANY: FORMER CONFORMED NAME: CollabRx, Inc. DATE OF NAME CHANGE: 20120926 FORMER COMPANY: FORMER CONFORMED NAME: TEGAL CORP /DE/ DATE OF NAME CHANGE: 19950918 4 1 ownership.xml X0306 4 2021-08-27 0 0000931059 Rennova Health, Inc. RNVA 0001578723 Diamantis Christopher Eric 1143 GLENDALE LANE NASHVILLE, TN 37204 0 0 1 0 Common Stock 2021-08-27 4 J 0 95000000 A 95450000 D Warrants to Purchase Common Stock 0.007 2021-08-27 4 J 0 47500000 A 2021-08-27 2024-08-27 Common Stock 47500000 47500000 D Series M Convertible Redeemable Preferred Stock 2021-08-27 4 J 0 570 D Common Stock 20180 D On August 27, 2021, pursuant to the terms of an Exchange Agreement with the Issuer, Mr. Diamantis exchanged 570 shares of Series M Redeemable Convertible Preferred Stock of the Issuer (the "Series M Preferred Stock") for 95,000,000 shares of Common Stock and Warrants to purchase 47,500,000 shares of Common Stock. The exercise of the Warrants and the conversion of the Series M Preferred Stock are each subject to ownership blockers of 4.99%. As a result, they are not exercisable or convertible as of August 27, 2021. The Series M Preferred Stock has no stated maturity date. The conversion price of the Series M Preferred Stock fluctuates with the price of the Common Stock. /s/ Christopher E. Diamantis 2021-09-27